⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11539656 | 0.97 | — | — | |
| SCHEMBL31118452 | 0.83 | — | — | |
| SCHEMBL30688903 | 0.79 | — | — | |
| SCHEMBL15423892 | 0.78 | — | — | |
| SCHEMBL16648522 | 0.78 | — | — | |
| SCHEMBL9193818 | 0.78 | — | — | |
| SCHEMBL1537015 | 0.78 | — | — | |
| SCHEMBL11540864 | 0.78 | — | — | |
| SCHEMBL11539798 | 0.78 | — | — | |
| SCHEMBL1359047 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119505065-A | Crosslinkable perfluorinated elastomer and preparation method and application thereof | 福建科润世纪氢能材料有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-116585292-A | Method for inducing anesthesia | 加利福尼亚大学董事会 | 2023-08-15 | — | — | CN | claimed |
| US-7993960-B2 | Electronic device and method of manufacturing the same | SAMSUNG MOBILE DISPLAY CO., LTD. (KR) | 2011-08-09 | — | — | US | claimed |
| US-7612033-B2 | Methods for delivering compounds into a cell | IMARX PHARMACEUTICAL CORP. (US) | 2009-11-03 | — | — | US | claimed |
| EP-1015039-B1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2008-08-27 | — | — | EP | claimed |
| EP-1933393-A1 | Method of manufacturing a substrate for an electronic device | Samsung SDI Co., Ltd. (KR) | 2008-06-18 | — | — | EP | claimed |
| EP-0935415-B1 | IN VITRO METHODS FOR DELIVERING NUCLEIC ACIDS INTO A CELL | IMARX PHARMACEUTICAL CORP (US) | 2006-11-22 | — | — | EP | claimed |
| US-7105151-B2 | Oxygen delivery agents and uses for the same | IMARX THERAPEUTICS, INC. (US) | 2006-09-12 | — | — | US | claimed |
| EP-1037673-B1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP (US) | 2006-08-23 | — | — | EP | claimed |
| EP-1039834-B1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP (US) | 2005-09-28 | — | — | EP | claimed |
| EP-0935415-A1 | METHODS FOR DELIVERING COMPOUNDS INTO A CELL | IMARX PHARMACEUTICAL CORP. (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1999030620-A1 | OPTOACOUSTIC CONTRAST AGENTS AND METHODS FOR THEIR USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-06-24 | — | — | WO | claimed |
| WO-1999025385-A1 | A METHOD OF INCREASING NUCLEIC ACID SYNTHESIS WITH ULTRASOUND | IMARX PHARMACEUTICAL CORP. (US) | 1999-05-27 | — | — | WO | claimed |
| EP-0901793-A1 | Thermal preactivation of gaseous precursor filled compositions | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-17 | — | — | EP | claimed |
| WO-1998057670-A1 | OXYGEN DELIVERY AGENTS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-12-23 | — | — | WO | claimed |
| WO-1998050041-A1 | NOVEL PRODRUGS COMPRISING FLUORINATED AMPHIPHILES | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | claimed |
| WO-1998050040-A1 | NOVEL LIPID SOLUBLE STEROID PRODRUGS | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | claimed |
| WO-1998042383-A1 | CHARGED LIPIDS AND USES FOR THE SAME | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | claimed |
| WO-1997040679-A1 | METHODS FOR DELIVERING COMPOUNDS INTO A CELL | IMARX PHARMACEUTICAL CORP. (US) | 1997-11-06 | — | — | WO | claimed |
| US-3930970-A | PHOTOLYSIS OF ALCOHOL NITRITES | RESEARCH INSTITUTE FOR MEDICINE AND CHEMISTRY INC. (US) | 1976-01-06 | — | — | US | claimed |